0 233

Denosumab-related osteonecrosis of the jaw: a case report and management based on pharmacokinetics

Authors
 Tae min You  ;  Kang-Hee Lee  ;  Soo-Hyeon Lee  ;  Wonse Park 
Citation
 Oral Surgery Oral Medicine Oral Pathology Oral Radiology, Vol.120(5) : 548-553, 2015 
Journal Title
 Oral Surgery Oral Medicine Oral Pathology Oral Radiology 
ISSN
 2212-4403 
Issue Date
2015
Abstract
Denosumab, a monoclonal antibody against the receptor activator for nuclear factor-kappa B ligand (RANKL), is a recently approved antiresorptive drug that suppresses osteoclast formation by targeting preosteclasts, in contrast to the traditional antiresorptive bisphosphonates that target mature osteoclasts. Osteonecrosis of the jaw (ONJ) is a well-known, if rare, side effect of bisphosphonate therapy; however, cases of ONJ have also been reported since 2010 in patients taking denosumab. We describe here a patient who developed ONJ while receiving denosumab; the pharmacokinetics of denosumab and bisphosphonates are discussed in the context of ONJ management.
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/141755
Full Text
http://www.sciencedirect.com/science/article/pii/S2212440315010962
DOI
10.1016/j.oooo.2015.07.017
Appears in Collections:
1. Journal Papers (연구논문) > 2. College of Dentistry (치과대학) > Dept. of Advanced General Dentistry (통합치의학과)
Yonsei Authors
박원서(Park, Wonse)
이강희(Lee, Kang Hee)
Export
RIS (EndNote)
XLS (Excel)
XML
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse